The Global Central Nervous System Disorders Therapeutics Market is estimated to be valued at US$ 131.3 million in 2021 and is expected to exhibit a CAGR of 6% during the forecast period 2022-2028. The central nervous system (CNS) is a complex system that regulates and coordinates bodily activity. Disorders of the central nervous system (CNS), also called central nervous system diseases. […]